A phase I study of DSTP3086S, an antibody-drug conjugate (ADC) targeting STEAP-1, in patients (pts) with metastatic castration-resistant prostate cancer (CRPC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 5024-5024 ◽  
Author(s):  
Daniel Costin Danila ◽  
Russell Zelig Szmulewitz ◽  
Ari David Baron ◽  
Celestia S. Higano ◽  
Howard I. Scher ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Castration Resistant Prostate Cancer ◽  
Antibody Drug Conjugate ◽  
Drug Conjugate ◽  
Castration Resistant ◽  
Antibody Drug

STEAP1 as a predictive biomarker for antibody-drug conjugate (ADC) activity in metastatic castration resistant prostate cancer (mCRPC).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 5029-5029 ◽  
Author(s):  
Daniel Costin Danila ◽  
Martin Fleisher ◽  
Jorge A. Carrasquillo ◽  
Houston Gilbert ◽  
Michael J. Morris ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Predictive Biomarker ◽  
Castration Resistant Prostate Cancer ◽  
Antibody Drug Conjugate ◽  
Drug Conjugate ◽  
Castration Resistant ◽  
Antibody Drug

scholarly journals A Phase I Study of Everolimus and Docetaxel in Patients With Castration-Resistant Prostate Cancer

2015 ◽  
Vol 13 (2) ◽  
pp. 113-123 ◽  
Author(s):  
Kevin D. Courtney ◽  
Judith B. Manola ◽  
Aymen A. Elfiky ◽  
Robert Ross ◽  
William K. Oh ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant

scholarly journals Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration‐Resistant Prostate Cancer

2016 ◽  
Vol 21 (5) ◽  
pp. 535 ◽  
Author(s):  
Neeraj Agarwal ◽  
Jean‐Pascal Machiels ◽  
Cristina Suárez ◽  
Nancy Lewis ◽  
Michaela Higgins ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Receptor Antagonist ◽  
Phase I Study ◽  
Prolactin Receptor ◽  
Metastatic Breast ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant

scholarly journals Phase I Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer

2018 ◽  
Vol 24 (21) ◽  
pp. 5225-5232 ◽  
Author(s):  
Shilpa Gupta ◽  
Luke T. Nordquist ◽  
Mark T. Fleming ◽  
William R. Berry ◽  
Jingsong Zhang ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Phase I ◽  
Phase I Study ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Receptor Inhibitor

scholarly journals Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer

PLoS ONE ◽  
2018 ◽  
Vol 13 (8) ◽  
pp. e0202709
Author(s):  
Michael T. Schweizer ◽  
Kathleen Haugk ◽  
Jožefa S. McKiernan ◽  
Roman Gulati ◽  
Heather H. Cheng ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document